Ambrosone, C.B., Freudenheim, J.L., Graham, S., Marshall, J.R., Vena, J.E., Brasure, J.R.et al.Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494–1501.CrossRefGoogle ScholarPubMed

Agundez, J.A., Jimenez-Jimenez, F.J., Luengo, A., Molina, J.A., Orti-Pareja, M., Vazquez, A.et al.Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson’s disease. Neurology 1998;51:1587–1592.CrossRefGoogle ScholarPubMed

Agundez, J.A.G., Olivera, M., Martinez, C., Ladero, J.M., Benitez, J.Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population. Pharmacogenetics 1996;6:423–428.CrossRefGoogle Scholar

Blouin, J.L., Dombroski, B.A., Nath, S.K., Lasseter, V.K., Wolyniec, P.S., Nestadt, G.et al.Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat. Genet 1998;20:70–73.CrossRefGoogle ScholarPubMed

Brzustowicz, L.M., Honer, W.G., Chow, E.W., Little, D., Hogan, J., Hodgkinson, K.et al.Linkage of familial schizophrenia to chromosome 13q32. Am. J. Hum. Genet 1999;65:1096–1103.CrossRefGoogle ScholarPubMed

Badner, J.A., Gershon, E.S.Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatr 2002;7:405–411.CrossRefGoogle Scholar

Blaveri, E., Kalsi, G., Lawrence, J., Quested, D., Moorey, H., Lamb, G.et al.Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1). Eur. J. Hum. Genet 2001;9:469–472.CrossRefGoogle Scholar

Bandmann, O., Vaughan, J., Holmans, P., Marsden, C.D., Wood, N.W.Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson’s disease. Lancet 1997;350:1136–1139.CrossRefGoogle ScholarPubMed

Butcher, N.J., Boukouvala, S., Sim, E., Minchin, R.F.Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J 2002;2:30–42.CrossRefGoogle ScholarPubMed

Blum, M., Demierre, A., Grant, D.M., Heim, M., Meyer, U.A.Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA 1991;88:5237–5241.CrossRefGoogle ScholarPubMed

Cascorbi, I., Drakoulis, N., Brockmoller, J., Maurer, A., Sperling, K., Roots, I.Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet 1995;57:581–592.Google ScholarPubMed

Curtis, D., Knight, J. Genecounting Program. http://www.mds.qmul.ac.uk/statgen/dcurtis.html. 2003. Accessed, November 8, 2005.Google Scholar

Deutsch, S.I., Rosse, R.B., Schwartz, B.L., Mastropaolo, J.A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol 2001;24:43–49.CrossRefGoogle ScholarPubMed

Dean, K., Murray, R.M.Environmental risk factors for psychosis. Dialogues Clin. Neurosci 2005;7:69–80.Google Scholar

Drozdz, M., Gierek, T., Jendryczko, A., Pilch, J., Piekarska, J.N-acetyltransferase phenotype of patients with cancer of the larynx. Neoplasma 1987;34:481–484.Google ScholarPubMed

De Leon, J., Diaz, F.J.A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviours. Schizophr. Res 2005;76:135–157.CrossRefGoogle Scholar

Gurling, H.M.D., Kalsi, G., Brynjolfson, J., Sigmundsson, T., Sherrington, R., Mankoo, B.S.et al.Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet 2001;68:661–673.CrossRefGoogle ScholarPubMed

Garte, S., Gaspari, L., Alexandrie, A.K., Ambrosone, C., Autrup, H., Autrup, J.L.et al.Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev 2000;10:1239–1248.Google Scholar

González, M.V., Alvarez, V., Pello, M.F., Menéndez, M.J., Suárez, C., Coto, E.Genetic polimorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J. Clin. Pathol 1998;51:294–298.CrossRefGoogle Scholar

Hovatta, I., Varilo, T., Suvisaari, J., Terwilliger, J.D., Ollikainen, V., Arajärvi, R.et al.A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet 1999;65:1114–1124.CrossRefGoogle Scholar

Hickman, D., Risch, A., Camilleri, P., Sim, E.Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics 1992;2:217–226.CrossRefGoogle ScholarPubMed

Hein, D.W., Doll, M.A., Fretland, A.J., Leff, M.A., Webb, S.J., Xiao, G.H.et al.Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev 2000;9:29–42.Google ScholarPubMed

Hein, D.W., Ferguson, R.J., Doll, M.A., Rustan, T.D., Gray, K.Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum. Mol. Genet 1994;3:729–734.Google ScholarPubMed

Hirvonen, A.Genetic factors in individual responses to environmental exposures. J. Occup. Environ. Med 1995;37:37–43.CrossRefGoogle ScholarPubMed

Ilett, K.F., David, B.M., Detchon, P., Castleden, W.M., Kwa, R.Acetylation phenotype in colorectal carcinoma. Cancer Res 1987;47:1466–1469.Google ScholarPubMed

Kelly, C., McCreadie, R.G.Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am. J. Psychiatry 1999;156:1751–1757.Google ScholarPubMed

Kaufmann, C.A., Suarez, B., Malaspina, D., Pepple, J., Svrakic, D., Markel, P.D.et al.NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am. J. Med. Genet 1998;81:282–289.3.0.CO;2-W>CrossRefGoogle ScholarPubMed

Kendler, K.S., MacLean, C.J., O’Neill, F.A., Burke, J., Murphy, B., Duke, F.et al.Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am. J. Psychiatry 1996;153:1534–1540.Google ScholarPubMed

Levinson, D.F., Wildenauer, D.B., Schwab, S.G., Albus, M., Hallmayer, J., Lerer, B.et al.Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am. J. Med. Genet 1996;67:580–594.Google Scholar

Lewis, C.M., Levinson, D.F., Wise, L.H., DeLisi, L.E., Straub, R.E., Hovatta, I.et al.Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet 2003;73:34–48.CrossRefGoogle Scholar

Lin, H.J., Han, C.Y., Lin, B.K., Hardy, S.Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, Blacks, Hispanics, and Whites: application to metabolic epidemiology. Am. J. Hum. Genet 1993;52:827–834.Google ScholarPubMed

Lin, H.J., Han, C.Y., Lin, B.K., Hardy, S.Ethnic distribution of slow acetilator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994;4:125–134.CrossRefGoogle Scholar

Matas, N., Thygesen, P., Stacey, M., Rich, A., Sim, E.Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet. Cell Genet 1997;77:290–295.CrossRefGoogle ScholarPubMed

O’Donovan, M.C., Owen, M.J.Candidate-gene association studies of schizophrenia. Am. J. Hum. Genet 1999;65:587–592.CrossRefGoogle ScholarPubMed

Pulver, A.E., Lasseter, V.K., Kasch, L., Wolyniec, P., Nestadt, G., Blouin, J.L.et al.Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am. J. Med. Genet 1995;60:252–260.CrossRefGoogle ScholarPubMed

Perneger, T.V.What’s wrong with Bonferroni adjustements. BMJ 1998 1236–1238.CrossRefGoogle Scholar

Rodrigo, L., Alvarez, V., Rodriguez, M., Perez, R., Alvarez, R., Coto, E.N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study. Scand. J. Gastroenterol 1999;34:303–307.Google ScholarPubMed

Risch, A., Wallace, D.M., Bathers, S., Sim, E.Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet 1995;4:231–236.CrossRefGoogle ScholarPubMed

Shaw, S.H., Kelly, M., Smith, A.B., Shields, G., Hopkins, P.J., Loftus, J.et al.A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet 1998;81:364–376.3.0.CO;2-T>CrossRefGoogle ScholarPubMed

Straub, R.E., MacLean, C.J., Ma, Y., Webb, B.T., Myakishev, M.V., Harris-Kerr, C.et al.Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatr 2002;7:542–559.CrossRefGoogle ScholarPubMed

Smythies, J.Endogenous neurotoxins relevant to schizophrenia. J. R. Soc. Med 1996;89:679–680.CrossRefGoogle Scholar

Vatsis, K.P., Martell, K.J., Weber, W.W.Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. USA 1991;88:6333–6337.CrossRefGoogle ScholarPubMed

Von Schmiedeberg, S., Fritsche, E., Ronnau, A.C., Specker, C., Golka, K., Richter-Hintz, D.et al.Polymorphisms of the xenobiotic metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv. Exp. Med. Biol 1999;455:147–152.CrossRefGoogle ScholarPubMed

Williams, N.M., Rees, M.I., Holmans, P., Norton, N., Cardno, A.G., Jones, L.A.et al.A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum. Mol. Genet 1999;8:1729–1739.CrossRefGoogle ScholarPubMed

World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Amened by the 41st World Medical Assembly, Hong Kong, September, 1989.Google Scholar